Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Hair-loss trials have increased, but need more diverse participants and standardized measures.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

The 5% minoxidil lotion without propylene glycol is effective, well-tolerated, and cosmetically acceptable for hair loss.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

5% minoxidil works better for hair growth and density, with minor irritation.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Scalp cooling effectively reduces hair loss from chemotherapy.

Adipose-derived stem cells (fat cells) show promise in treating hair loss in both men and women.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

LB-P9 supplements improve hair health and satisfaction without side effects.

Fractional Er:YAG laser with PRP is more effective and has fewer side effects than microneedling with PRP for vitiligo.

BeauTop improves hair growth in androgenetic alopecia patients.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

The authors agree that standardizing how PRP methods are reported could help compare results, but note that the link between PRP's contents and hair growth is unclear, and recommend avoiding split-scalp designs in future trials.

Reflexology massage helps hair regrowth in women after chemotherapy.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Mesenchymal stem cell-derived exosomes show promise for treating skin and tissue diseases.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.